Last reviewed: June 11, 2026
Last updated: June 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work best when placed in the correct subcutaneous layer of skin, typically between 45 and 90 days of weekly dosing. Rotating your injection sites prevents tissue damage and ensures consistent medication delivery into your system. Understanding where and how to inject safely is an essential part of your personalized weight loss therapy with PlexusDx.
Approved Semaglutide Injection Sites on Your Body
Semaglutide is designed for subcutaneous injection, meaning the needle goes into the fatty tissue just below your skin but above the muscle layer. The FDA-approved injection sites include the belly, thigh, and upper arm, each offering reliable absorption when performed correctly. These three areas have sufficient subcutaneous fat in most patients and are easy to access without assistance.
Your abdomen is the most forgiving site for beginners because the skin stretches easily and you can see the injection area clearly while standing or sitting. The thigh offers a second practical option, particularly the outer portion where you have clear landmarks for proper placement. Your upper arm injection site works best if you can reach comfortably or have a partner assist, as the triceps area provides good fatty tissue depth.
Clinical data shows that rotating between these three body regions reduces the risk of developing lipohypertrophy, a condition where repeated injections in the same spot cause abnormal fat buildup. This complication can affect how your body absorbs the medication and lead to inconsistent weight loss results. Spacing out your injection sites keeps your skin healthy and your treatment effective throughout your therapy.
How to Rotate Injection Sites Correctly
Site rotation means using a different location each week rather than repeatedly injecting in the same spot. A practical approach is to designate four zones within each body region: upper right abdomen, upper left abdomen, lower right abdomen, and lower left abdomen. After four weeks of belly injections, switch to your right thigh, then left thigh after another four weeks, followed by your upper arms before returning to the abdomen.
Within each injection zone, maintain at least one inch of space from your previous injection site to avoid overlapping tissue trauma. This distance guideline prevents bruising, soreness, and the inflammatory response that comes from repeated punctures in the exact same location. Many patients find it helpful to mark their four abdominal zones with a washable pen or keep a simple injection log to track which site they used each week.
Rotating between your abdomen, thighs, and arms also helps you identify which location feels most comfortable and has the best absorption for your body type. Some patients notice less irritation when injecting into areas with more cushioning, while others prefer sites that are easier to reach. Your comfort and consistency matter because patients who feel confident with their injection technique tend to stay on treatment longer and see better results.
Proper Needle Depth and Injection Technique
Semaglutide pens and needles are engineered to deliver medication to the subcutaneous fat layer, which sits between your skin and muscle. Standard pen needles range from 4mm to 8mm in length, and PlexusDx-dispensed medications come with clear instructions on which needle size to use based on your injection site and body composition. Inserting the needle at a 90-degree angle to your skin ensures it reaches the fatty tissue where absorption occurs most reliably.
Before injecting, pinch a fold of skin at your chosen site to elevate the subcutaneous layer and create distance between the needle tip and underlying muscle. Insert the needle quickly but smoothly, then hold it steady for three to five seconds to allow the medication to disperse into surrounding tissue. Remove the needle at the same angle you inserted it, then release the skin fold and gently massage the area for five to ten seconds to improve distribution.
Never inject into areas that are bruised, tender, swollen, or scarred from previous injections, as these tissues cannot absorb medication effectively. If you notice redness that lasts longer than a few hours or hardened bumps forming under your skin, contact your PlexusDx care team to discuss whether your injection depth or site rotation needs adjustment. Proper technique prevents complications and maintains the steady medication levels your body needs for sustained weight loss.
Minimizing Pain, Bruising, and Side Effects at Injection Sites
Needle anxiety and injection-site discomfort discourage many patients from staying consistent with their therapy, but several evidence-based strategies reduce both pain and bruising. Injecting at room temperature rather than cold medication causes less tissue irritation, so remove your semaglutide from the refrigerator five to ten minutes before use. Clean your skin with an alcohol pad and let it air-dry completely, as injecting into wet skin can increase stinging and affect medication absorption.
Bruising at injection sites happens when the needle damages small blood vessels, but you can minimize this by avoiding areas with visible veins and by applying gentle pressure with a clean gauze pad after injection rather than rubbing. Some patients find that rotating to a different body region each week naturally reduces bruising because they use less frequently injected areas. If bruising persists or worsens, it may indicate you are injecting too aggressively or not rotating sites adequately.
Lipohypertrophy, the buildup of fatty tissue at repeated injection sites, is one of the most common long-term complications of injectable therapies but is almost entirely preventable through proper site rotation. This condition can develop silently over months without pain or obvious symptoms, making site rotation discipline essential even if you feel fine. PlexusDx patients who follow a structured rotation plan and maintain detailed injection records report significantly fewer complications and more consistent medication effectiveness over time.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into any area of my body?
Semaglutide is approved only for subcutaneous injection into the belly, thigh, or upper arm. Never inject into muscle, veins, or areas with active bruising, scarring, or inflammation. Injecting in non-approved sites or at the wrong depth reduces medication absorption and increases infection risk.
How many injection sites can I use before switching areas?
You can designate four separate zones within each body region (for example, four abdominal quadrants) before moving to the next region. Spacing injections one inch apart within each zone and rotating regions every four weeks prevents lipohypertrophy and maintains consistent absorption throughout your treatment.
Is it okay to inject into the same spot if it doesn't hurt?
No. Repeated injections into the same spot cause lipohypertrophy even without pain or visible symptoms. This fatty tissue buildup prevents proper medication absorption and can eventually become cosmetically noticeable. Strict site rotation is essential for long-term treatment success.
What should I do if I develop bruising or swelling after injection?
Minor bruising is normal and typically resolves within a few days. Apply gentle pressure with clean gauze immediately after injection, avoid that site for at least one week, and rotate to a different area. If bruising is severe, spreads rapidly, or causes numbness, contact your PlexusDx care team right away.
Does the PlexusDx Precision Peptide Genetic Test help with injection site selection?
The Precision Peptide Genetic Test identifies your genetic predisposition to GLP-1 receptor sensitivity and peptide pathway activation, which informs personalized dosing and medication choice. While genetic testing does not directly affect injection site technique, it helps ensure you are on the right medication formulation for your genetics, maximizing effectiveness regardless of where you inject.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How is Tirzepatide Different from Semaglutide?
How Often Do You Need to Take GLP-1s? Understanding Your Medication Schedule